Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Alpha- Antitrypsin Deficiency Treatment industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Grifols, SA
Arrowhead Pharmaceuticals, Inc
Alnylam Pharmaceuticals, Inc
ProMetic Life Sciences Inc
Cevec Pharmaceuticals GmbH
Ionis Pharmaceuticals, Inc
Dicerna Pharmaceuticals, Inc
Carolus Therapeutics, Inc
rEVO Biologics, Inc
Inhibrx
Adverum Biotechnologies, Inc
Applied Genetic Technologies Corporation
International Stem Cell Corporation
Editas Medicine, Inc
Sangamo BioSciences, Inc
Digna Biotech, SL
By Type:
CT-2009
ALNAAT-02
ARO-AAT
Others
POL-6014
By Application:
Hospital
Clinic
Others
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Alpha- Antitrypsin Deficiency Treatment Market Overview 2018-2029
-
1.1 China Alpha- Antitrypsin Deficiency Treatment Industry Development Overview
-
1.2 China Alpha- Antitrypsin Deficiency Treatment Industry Development History
-
1.3 China Alpha- Antitrypsin Deficiency Treatment Industry Market Size (2018-2029)
-
1.4 China Alpha- Antitrypsin Deficiency Treatment Market Analysis by Type from Production Side
-
1.4.1 China Alpha- Antitrypsin Deficiency Treatment Production Volume, Production Value and Growth Rate of CT-2009 (2018-2029)
-
1.4.2 China Alpha- Antitrypsin Deficiency Treatment Production Volume, Production Value and Growth Rate of ALNAAT-02 (2018-2029)
-
1.4.3 China Alpha- Antitrypsin Deficiency Treatment Production Volume, Production Value and Growth Rate of ARO-AAT (2018-2029)
-
1.4.4 China Alpha- Antitrypsin Deficiency Treatment Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
1.4.5 China Alpha- Antitrypsin Deficiency Treatment Production Volume, Production Value and Growth Rate of POL-6014 (2018-2029)
-
1.5 China Alpha- Antitrypsin Deficiency Treatment Market Analysis by Application from Consumption End
-
1.5.1 China Alpha- Antitrypsin Deficiency Treatment Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)
-
1.5.2 China Alpha- Antitrypsin Deficiency Treatment Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)
-
1.5.3 China Alpha- Antitrypsin Deficiency Treatment Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
1.6 China Alpha- Antitrypsin Deficiency Treatment Market Analysis by Region
-
1.6.1 North China Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2018-2029
Chapter 2 China Alpha- Antitrypsin Deficiency Treatment Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Alpha- Antitrypsin Deficiency Treatment Market Status and Competition at home and abroad in 2023
-
2.2.2 China Alpha- Antitrypsin Deficiency Treatment Market Status and Competition Analysis in 2023
-
2.2.3 China Alpha- Antitrypsin Deficiency Treatment Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Alpha- Antitrypsin Deficiency Treatment Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Alpha- Antitrypsin Deficiency Treatment Industry Development
Chapter 3 Alpha- Antitrypsin Deficiency TreatmentIndustry Chain Analysis
-
3.1 Alpha- Antitrypsin Deficiency Treatment Industry Chain
-
3.2 Alpha- Antitrypsin Deficiency Treatment Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Alpha- Antitrypsin Deficiency Treatment Market
-
3.3 Alpha- Antitrypsin Deficiency Treatment Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Alpha- Antitrypsin Deficiency Treatment Market
Chapter 4 China Alpha- Antitrypsin Deficiency Treatment Market, by Type
-
4.1 China Alpha- Antitrypsin Deficiency Treatment Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Alpha- Antitrypsin Deficiency Treatment Total Production Volume and Growth Rate from Production Side
-
4.5 China Alpha- Antitrypsin Deficiency Treatment Production Volume and Growth Rate, by Type
-
4.5.1 China Alpha- Antitrypsin Deficiency Treatment Production Volume and Growth Rate of CT-2009
-
4.5.2 China Alpha- Antitrypsin Deficiency Treatment Production Volume and Growth Rate of ALNAAT-02
-
4.5.3 China Alpha- Antitrypsin Deficiency Treatment Production Volume and Growth Rate of ARO-AAT
-
4.5.4 China Alpha- Antitrypsin Deficiency Treatment Production Volume and Growth Rate of Others
-
4.5.5 China Alpha- Antitrypsin Deficiency Treatment Production Volume and Growth Rate of POL-6014
Chapter 5 China Alpha- Antitrypsin Deficiency Treatment Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Alpha- Antitrypsin Deficiency Treatment Total Market Size and Growth Rate from Consumption End
-
5.5 China Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate, by Application
-
5.5.1 China Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate of Hospital
-
5.5.2 China Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate of Clinic
-
5.5.3 China Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate of Others
Chapter 6 China Alpha- Antitrypsin Deficiency Treatment Market, by Region
-
6.1 China Alpha- Antitrypsin Deficiency Treatment Production Volume and Production Value, by Region
-
6.2 China Alpha- Antitrypsin Deficiency Treatment Sales Volume and Sales Value, by Region
Chapter 7 North China Alpha- Antitrypsin Deficiency Treatment Market Analysis
-
7.1 North China Alpha- Antitrypsin Deficiency Treatment Market, by Type
-
7.2 North China Alpha- Antitrypsin Deficiency Treatment Market, by Application
Chapter 8 Central China Alpha- Antitrypsin Deficiency Treatment Market Analysis
-
8.1 Central China Alpha- Antitrypsin Deficiency Treatment Market, by Type
-
8.2 Central China Alpha- Antitrypsin Deficiency Treatment Market, by Application
Chapter 9 South China Alpha- Antitrypsin Deficiency Treatment Market Analysis
-
9.1 South China Alpha- Antitrypsin Deficiency Treatment Market, by Type
-
9.2 South China Alpha- Antitrypsin Deficiency Treatment Market, by Application
Chapter 10 East China Alpha- Antitrypsin Deficiency Treatment Market Analysis
-
10.1 East China Alpha- Antitrypsin Deficiency Treatment Market, by Type
-
10.2 East China Alpha- Antitrypsin Deficiency Treatment Market, by Application
Chapter 11 Northeast China Alpha- Antitrypsin Deficiency Treatment Market Analysis
-
11.1 Northeast China Alpha- Antitrypsin Deficiency Treatment Market, by Type
-
11.2 Northeast China Alpha- Antitrypsin Deficiency Treatment Market, by Application
Chapter 12 Southwest China Alpha- Antitrypsin Deficiency Treatment Market Analysis
-
12.1 Southwest China Alpha- Antitrypsin Deficiency Treatment Market, by Type
-
12.2 Southwest China Alpha- Antitrypsin Deficiency Treatment Market, by Application
Chapter 13 Northwest China Alpha- Antitrypsin Deficiency Treatment Market Analysis
-
13.1 Northwest China Alpha- Antitrypsin Deficiency Treatment Market, by Type
-
13.2 Northwest China Alpha- Antitrypsin Deficiency Treatment Market, by Application
Chapter 14 Company Profiles
-
14.1 Grifols, SA
-
14.1.1 Grifols, SA Company Profile
-
14.1.2 Grifols, SA Alpha- Antitrypsin Deficiency Treatment Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Arrowhead Pharmaceuticals, Inc
-
14.2.1 Arrowhead Pharmaceuticals, Inc Company Profile
-
14.2.2 Arrowhead Pharmaceuticals, Inc Alpha- Antitrypsin Deficiency Treatment Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Alnylam Pharmaceuticals, Inc
-
14.3.1 Alnylam Pharmaceuticals, Inc Company Profile
-
14.3.2 Alnylam Pharmaceuticals, Inc Alpha- Antitrypsin Deficiency Treatment Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 ProMetic Life Sciences Inc
-
14.4.1 ProMetic Life Sciences Inc Company Profile
-
14.4.2 ProMetic Life Sciences Inc Alpha- Antitrypsin Deficiency Treatment Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Cevec Pharmaceuticals GmbH
-
14.5.1 Cevec Pharmaceuticals GmbH Company Profile
-
14.5.2 Cevec Pharmaceuticals GmbH Alpha- Antitrypsin Deficiency Treatment Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Ionis Pharmaceuticals, Inc
-
14.6.1 Ionis Pharmaceuticals, Inc Company Profile
-
14.6.2 Ionis Pharmaceuticals, Inc Alpha- Antitrypsin Deficiency Treatment Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Dicerna Pharmaceuticals, Inc
-
14.7.1 Dicerna Pharmaceuticals, Inc Company Profile
-
14.7.2 Dicerna Pharmaceuticals, Inc Alpha- Antitrypsin Deficiency Treatment Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Carolus Therapeutics, Inc
-
14.8.1 Carolus Therapeutics, Inc Company Profile
-
14.8.2 Carolus Therapeutics, Inc Alpha- Antitrypsin Deficiency Treatment Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 rEVO Biologics, Inc
-
14.9.1 rEVO Biologics, Inc Company Profile
-
14.9.2 rEVO Biologics, Inc Alpha- Antitrypsin Deficiency Treatment Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 Inhibrx
-
14.10.1 Inhibrx Company Profile
-
14.10.2 Inhibrx Alpha- Antitrypsin Deficiency Treatment Market Performance
-
14.10.3 Product&Service Introduction
-
14.11 Adverum Biotechnologies, Inc
-
14.11.1 Adverum Biotechnologies, Inc Company Profile
-
14.11.2 Adverum Biotechnologies, Inc Alpha- Antitrypsin Deficiency Treatment Market Performance
-
14.11.3 Product&Service Introduction
-
14.12 Applied Genetic Technologies Corporation
-
14.12.1 Applied Genetic Technologies Corporation Company Profile
-
14.12.2 Applied Genetic Technologies Corporation Alpha- Antitrypsin Deficiency Treatment Market Performance
-
14.12.3 Product&Service Introduction
-
14.13 International Stem Cell Corporation
-
14.13.1 International Stem Cell Corporation Company Profile
-
14.13.2 International Stem Cell Corporation Alpha- Antitrypsin Deficiency Treatment Market Performance
-
14.13.3 Product&Service Introduction
-
14.14 Editas Medicine, Inc
-
14.14.1 Editas Medicine, Inc Company Profile
-
14.14.2 Editas Medicine, Inc Alpha- Antitrypsin Deficiency Treatment Market Performance
-
14.14.3 Product&Service Introduction
-
14.15 Sangamo BioSciences, Inc
-
14.15.1 Sangamo BioSciences, Inc Company Profile
-
14.15.2 Sangamo BioSciences, Inc Alpha- Antitrypsin Deficiency Treatment Market Performance
-
14.15.3 Product&Service Introduction
-
14.16 Digna Biotech, SL
-
14.16.1 Digna Biotech, SL Company Profile
-
14.16.2 Digna Biotech, SL Alpha- Antitrypsin Deficiency Treatment Market Performance
-
14.16.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Alpha- Antitrypsin Deficiency Treatment Industry Research Conclusions
-
15.2 Alpha- Antitrypsin Deficiency Treatment Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Alpha- Antitrypsin Deficiency Treatment Industry Market Size (2018-2029)
-
Figure China Alpha- Antitrypsin Deficiency Treatment Production Volume, Production Value and Growth Rate of CT-2009 (2018-2029)
-
Figure China Alpha- Antitrypsin Deficiency Treatment Production Volume, Production Value and Growth Rate of ALNAAT-02 (2018-2029)
-
Figure China Alpha- Antitrypsin Deficiency Treatment Production Volume, Production Value and Growth Rate of ARO-AAT (2018-2029)
-
Figure China Alpha- Antitrypsin Deficiency Treatment Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
Figure China Alpha- Antitrypsin Deficiency Treatment Production Volume, Production Value and Growth Rate of POL-6014 (2018-2029)
-
Figure China Alpha- Antitrypsin Deficiency Treatment Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)
-
Figure China Alpha- Antitrypsin Deficiency Treatment Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)
-
Figure China Alpha- Antitrypsin Deficiency Treatment Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
Figure North China Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2018-2029
-
Figure Central China Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2018-2029
-
Figure South China Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2018-2029
-
Figure East China Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2018-2029
-
Figure Alpha- Antitrypsin Deficiency Treatment Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Alpha- Antitrypsin Deficiency Treatment Market Share by Type in 2018
-
Figure China Alpha- Antitrypsin Deficiency Treatment Market Share by Type in 2023
-
Figure China Alpha- Antitrypsin Deficiency Treatment Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Alpha- Antitrypsin Deficiency Treatment Production Volume and Growth Rate of CT-2009 (2018-2023)
-
Figure China Alpha- Antitrypsin Deficiency Treatment Production Volume and Growth Rate of ALNAAT-02 (2018-2023)
-
Figure China Alpha- Antitrypsin Deficiency Treatment Production Volume and Growth Rate of ARO-AAT (2018-2023)
-
Figure China Alpha- Antitrypsin Deficiency Treatment Production Volume and Growth Rate of Others (2018-2023)
-
Figure China Alpha- Antitrypsin Deficiency Treatment Production Volume and Growth Rate of POL-6014 (2018-2023)
-
Figure China Alpha- Antitrypsin Deficiency Treatment Market Share by Application in 2018
-
Figure China Alpha- Antitrypsin Deficiency Treatment Market Share by Application in 2023
-
Figure China Alpha- Antitrypsin Deficiency Treatment Total Market Size and Growth Rate from Consumption End
-
Figure China Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate of Hospital (2018-2023)
-
Figure China Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate of Clinic (2018-2023)
-
Figure China Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate of Others (2018-2023)
-
Table China Alpha- Antitrypsin Deficiency Treatment Production Volume by Region (2018-2023)
-
Table China Alpha- Antitrypsin Deficiency Treatment Production Volume Share by Region (2018-2023)
-
Figure China Alpha- Antitrypsin Deficiency Treatment Production Volume Share by Region (2018-2023)
-
Table China Alpha- Antitrypsin Deficiency Treatment Production Value by Region (2018-2023)
-
Table China Alpha- Antitrypsin Deficiency Treatment Production Value Share by Region (2018-2023)
-
Figure China Alpha- Antitrypsin Deficiency Treatment Production Value Share by Region (2018-2023)
-
Table China Alpha- Antitrypsin Deficiency Treatment Sales Volume by Region (2018-2023)
-
Table China Alpha- Antitrypsin Deficiency Treatment Sales Volume Share by Region (2018-2023)
-
Figure China Alpha- Antitrypsin Deficiency Treatment Sales Volume Share by Region (2018-2023)
-
Table China Alpha- Antitrypsin Deficiency Treatment Sales Value by Region (2018-2023)
-
Table China Alpha- Antitrypsin Deficiency Treatment Sales Value Share by Region (2018-2023)
-
Figure China Alpha- Antitrypsin Deficiency Treatment Sales Value Share by Region (2018-2023)
-
Table North China Alpha- Antitrypsin Deficiency Treatment Production Volume by Type (2018-2023)
-
Table North China Alpha- Antitrypsin Deficiency Treatment Production Volume Share by Type (2018-2023)
-
Figure North China Alpha- Antitrypsin Deficiency Treatment Production Volume Share by Type (2018-2023)
-
Table North China Alpha- Antitrypsin Deficiency Treatment Sales Volume by Application (2018-2023)
-
Table North China Alpha- Antitrypsin Deficiency Treatment Sales Volume Share by Application (2018-2023)
-
Figure North China Alpha- Antitrypsin Deficiency Treatment Sales Volume Share by Application (2018-2023)
-
Table Central China Alpha- Antitrypsin Deficiency Treatment Production Volume by Type (2018-2023)
-
Table Central China Alpha- Antitrypsin Deficiency Treatment Production Volume Share by Type (2018-2023)
-
Figure Central China Alpha- Antitrypsin Deficiency Treatment Production Volume Share by Type (2018-2023)
-
Table Central China Alpha- Antitrypsin Deficiency Treatment Sales Volume by Application (2018-2023)
-
Table Central China Alpha- Antitrypsin Deficiency Treatment Sales Volume Share by Application (2018-2023)
-
Figure Central China Alpha- Antitrypsin Deficiency Treatment Sales Volume Share by Application (2018-2023)
-
Table South China Alpha- Antitrypsin Deficiency Treatment Production Volume by Type (2018-2023)
-
Table South China Alpha- Antitrypsin Deficiency Treatment Production Volume Share by Type (2018-2023)
-
Figure South China Alpha- Antitrypsin Deficiency Treatment Production Volume Share by Type (2018-2023)
-
Table South China Alpha- Antitrypsin Deficiency Treatment Sales Volume by Application (2018-2023)
-
Table South China Alpha- Antitrypsin Deficiency Treatment Sales Volume Share by Application (2018-2023)
-
Figure South China Alpha- Antitrypsin Deficiency Treatment Sales Volume Share by Application (2018-2023)
-
Table East China Alpha- Antitrypsin Deficiency Treatment Production Volume by Type (2018-2023)
-
Table East China Alpha- Antitrypsin Deficiency Treatment Production Volume Share by Type (2018-2023)
-
Figure East China Alpha- Antitrypsin Deficiency Treatment Production Volume Share by Type (2018-2023)
-
Table East China Alpha- Antitrypsin Deficiency Treatment Sales Volume by Application (2018-2023)
-
Table East China Alpha- Antitrypsin Deficiency Treatment Sales Volume Share by Application (2018-2023)
-
Figure East China Alpha- Antitrypsin Deficiency Treatment Sales Volume Share by Application (2018-2023)
-
Table Northeast China Alpha- Antitrypsin Deficiency Treatment Production Volume by Type (2018-2023)
-
Table Northeast China Alpha- Antitrypsin Deficiency Treatment Production Volume Share by Type (2018-2023)
-
Figure Northeast China Alpha- Antitrypsin Deficiency Treatment Production Volume Share by Type (2018-2023)
-
Table Northeast China Alpha- Antitrypsin Deficiency Treatment Sales Volume by Application (2018-2023)
-
Table Northeast China Alpha- Antitrypsin Deficiency Treatment Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Alpha- Antitrypsin Deficiency Treatment Sales Volume Share by Application (2018-2023)
-
Table Southwest China Alpha- Antitrypsin Deficiency Treatment Production Volume by Type (2018-2023)
-
Table Southwest China Alpha- Antitrypsin Deficiency Treatment Production Volume Share by Type (2018-2023)
-
Figure Southwest China Alpha- Antitrypsin Deficiency Treatment Production Volume Share by Type (2018-2023)
-
Table Southwest China Alpha- Antitrypsin Deficiency Treatment Sales Volume by Application (2018-2023)
-
Table Southwest China Alpha- Antitrypsin Deficiency Treatment Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Alpha- Antitrypsin Deficiency Treatment Sales Volume Share by Application (2018-2023)
-
Table Northwest China Alpha- Antitrypsin Deficiency Treatment Production Volume by Type (2018-2023)
-
Table Northwest China Alpha- Antitrypsin Deficiency Treatment Production Volume Share by Type (2018-2023)
-
Figure Northwest China Alpha- Antitrypsin Deficiency Treatment Production Volume Share by Type (2018-2023)
-
Table Northwest China Alpha- Antitrypsin Deficiency Treatment Sales Volume by Application (2018-2023)
-
Table Northwest China Alpha- Antitrypsin Deficiency Treatment Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Alpha- Antitrypsin Deficiency Treatment Sales Volume Share by Application (2018-2023)
-
Table Grifols, SA Company Profile
-
Table Grifols, SA Alpha- Antitrypsin Deficiency Treatment Revenue, Price and Gross (2018-2023)
-
Table Arrowhead Pharmaceuticals, Inc Company Profile
-
Table Arrowhead Pharmaceuticals, Inc Alpha- Antitrypsin Deficiency Treatment Revenue, Price and Gross (2018-2023)
-
Table Alnylam Pharmaceuticals, Inc Company Profile
-
Table Alnylam Pharmaceuticals, Inc Alpha- Antitrypsin Deficiency Treatment Revenue, Price and Gross (2018-2023)
-
Table ProMetic Life Sciences Inc Company Profile
-
Table ProMetic Life Sciences Inc Alpha- Antitrypsin Deficiency Treatment Revenue, Price and Gross (2018-2023)
-
Table Cevec Pharmaceuticals GmbH Company Profile
-
Table Cevec Pharmaceuticals GmbH Alpha- Antitrypsin Deficiency Treatment Revenue, Price and Gross (2018-2023)
-
Table Ionis Pharmaceuticals, Inc Company Profile
-
Table Ionis Pharmaceuticals, Inc Alpha- Antitrypsin Deficiency Treatment Revenue, Price and Gross (2018-2023)
-
Table Dicerna Pharmaceuticals, Inc Company Profile
-
Table Dicerna Pharmaceuticals, Inc Alpha- Antitrypsin Deficiency Treatment Revenue, Price and Gross (2018-2023)
-
Table Carolus Therapeutics, Inc Company Profile
-
Table Carolus Therapeutics, Inc Alpha- Antitrypsin Deficiency Treatment Revenue, Price and Gross (2018-2023)
-
Table rEVO Biologics, Inc Company Profile
-
Table rEVO Biologics, Inc Alpha- Antitrypsin Deficiency Treatment Revenue, Price and Gross (2018-2023)
-
Table Inhibrx Company Profile
-
Table Inhibrx Alpha- Antitrypsin Deficiency Treatment Revenue, Price and Gross (2018-2023)
-
Table Adverum Biotechnologies, Inc Company Profile
-
Table Adverum Biotechnologies, Inc Alpha- Antitrypsin Deficiency Treatment Revenue, Price and Gross (2018-2023)
-
Table Applied Genetic Technologies Corporation Company Profile
-
Table Applied Genetic Technologies Corporation Alpha- Antitrypsin Deficiency Treatment Revenue, Price and Gross (2018-2023)
-
Table International Stem Cell Corporation Company Profile
-
Table International Stem Cell Corporation Alpha- Antitrypsin Deficiency Treatment Revenue, Price and Gross (2018-2023)
-
Table Editas Medicine, Inc Company Profile
-
Table Editas Medicine, Inc Alpha- Antitrypsin Deficiency Treatment Revenue, Price and Gross (2018-2023)
-
Table Sangamo BioSciences, Inc Company Profile
-
Table Sangamo BioSciences, Inc Alpha- Antitrypsin Deficiency Treatment Revenue, Price and Gross (2018-2023)
-
Table Digna Biotech, SL Company Profile
-
Table Digna Biotech, SL Alpha- Antitrypsin Deficiency Treatment Revenue, Price and Gross (2018-2023)
-
